Compass Therapeutics CMPX
NASDAQ CMPX
$1.02 -0.08 (-6.82%)
As of: Sep 30, 2026 · 2:53 PM EDT

Compass Therapeutics (CMPX) Long-Term Debt Repayments (2021)

Updated

Compass Therapeutics' Long-Term Debt Repayments came in at $3.75 million for Q4 2021, up 100.0% from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Long-Term Debt Repayments (2021) Analysis & Trends

For FY2021, Compass Therapeutics' Long-Term Debt Repayments was $9.38 million, up 66.7% from FY2020.

  • Going back by year, Long-Term Debt Repayments was $5.63 million in FY2020.
  • Business Quant data shows CMPX's Long-Term Debt Repayments at $1.88 million (Q3 2021), $1.88 million (Q2 2021) and $1.88 million (Q1 2021) in the three quarters before Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 2.00 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -2.45 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 17.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Compass Therapeutics 198.10 Mn 198.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 3.75 Mn
Sep 30, 2021 1.88 Mn
Jun 20, 2021 1.88 Mn
Mar 31, 2021 1.88 Mn
API Access

Compass Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CMPX&period=max&api_key=YOUR_API_KEY